Santhera Pharmaceuticals
Liestal
About Santhera Pharmaceuticals
Santhera Pharmaceuticals (SIX: SANN) is a Swiss specialty pharmaceutical company focusing on the development and marketing of innovative pharmaceutical products for the treatment of mitochondrial and neuromuscular diseases. This area of high unmet medical need includes many orphan and niche indications with no current therapy.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $309.4M
- Funding stage: IPO
- Last round: Post-IPO Debt (Nov 2025)
- Ticker: six:SANN
- Website: santhera.com
- Phone: +41 61 906 89 50
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/santhera-pharmaceuticals-82280 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.